Leveraging artificial intelligence (AI), computational pathology, and digital health technologies, the expanded operations will strengthen AstraZeneca’s R&D capabilities and enhance clinical trial design in oncology, immunology, and infectious diseases.
Ontario's life sciences sector offers unparalleled opportunities for companies changing the face of healthcare.
Connect with us today to learn how we can help your next business expansion.
